FORTIS Fortis Healthcare Q2 FY26 results (Jul–Sep 2025) and concall
Fortis Healthcare delivered a strong Q2 FY26, marked by robust revenue and EBITDA growth across both hospital and diagnostics segments. The company expanded its operational bed capacity and improved key hospital metrics like occupancy and ARPOB. While diagnostics volumes saw a slight dip due to specific business changes, margins remained strong. Strategic expansion initiatives are progressing, though the FMRI facility commissioning is slightly delayed.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q2 FY26: revenue up 27.7%, net profit up 212.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|
| Revenue | 357 | 367 | 388 | 433 | 456 +28% |
| EBITDA | 60 | 67 | 71 | 88 | 100 +67% |
| Net profit | 40 | 40 | -42 | 52 | 125 +213% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
